Pokaż cały numer - Farmaceutyczny Przegląd Naukowy

Adres do korespondencji:
doc. dr hab. n. med. Maciej Małecki
Zakład Biologii Komórki
Centrum Onkologii-Instytut im. M. Skłodowskiej-Curie
ul. Roentgena 5, 02-781 Warszawa
tel. 022 546 26 20
mahan@poczta.wp.pl
copyright © 2009 Grupa dr. A. R. Kwiecińskiego ISSN 1425-5073
Piśmiennictwo
13. Zhang Y i wsp.: AAV-mediated TRAIL gene expression
driven by hTERT promoter suppressed human
1. www.wiley.co.uk/genmed
hepatocellular carcinoma growth in mice. Life Science
2. Małecki M, Woźniak A, Janik P. Wirusy związane z ade- 2008;82: 1154-61.
nowirusami (AAV). Postępy Biochem 2008; 54: 57-63. 14. Samulski RJ i wsp.: Targeted integration of adeno-asso-
3. Małecki M. Wirusowe strategie w terapii genowej ze ciated virus (AAV) into human chromosome 19. EMBO
szczególnym uwzględnieniem wektorów konstruowa- 1991; 10: 3941-50.
nych z wirusów związanych z adenowirusami (AAV). 15. Ma HI i wsp.: Intratumoral gene therapy of malignant
Postępy Biol. Kom 2004; 31: 47-57.
brain tumor in a rat model with angiostatin delivered by
4. Farmakopea Europejska 2006.
adeno-associated viral (AAV) vector. Gene Ther 2002;
5. Stribbling SM i wsp.: Regressions of established breast 9: 2-11.
cancer xenografts by carboxypeptidase G2 suicide gene 16. Shi W i wsp.: Adeno-associated virus-mediated gene
therapy and the prodrug CMDA are due to a bystander transfer of endostatin inhibits angiogenesis and tumor
effect. Hum. Gene Ther 2000; 11: 285-92.
growth in vivo. Cancer Gene Ther 2002; 9: 513-21.
6. Kanazawa T i wsp.: Suicide gene therapy using AAV- 17. Ponnazhagan S i wsp.: Adeno-Associated Virus
HSVtk/ganciclovir in combination with irradiation re- 2-Mediated Antiangiogenic Cancer Gene Therapy:
sults in regression of human head and neck cancer xeno- Long-Term Efficacy of a Vector Encoding Angiostatin
rafts in nude mice. Gene Ther 2003; 10: 51-58.
and Endostatin over Vectors Encoding a Single Factor.
7. Li ZB i wsp.: Recombinant AAV-mediated HSVtk gene Cancer Res 2004; 64: 1781-7.
transfer with direct intratumoral injections and Tet-On 18. Anderson R i wsp.: Construction and biological charegulation
for implanted human breast cancer. BMC racterization of an interleukin-12 fusion protein (Fle-
Cancer 2006; 6: 66.
xi-12): delivery to acute myeloid leukemic blasts
8. Schoensiegel F i wsp.: MIA (melanoma inhibitory acti- using adeno-associated virus. Hum. Gene Ther 1997;
vity) promoter mediated tissue-specific suicide gene the- 8: 1125-35.
rapy of malignant melanoma. Cancer Gene Ther 2004; 19. Zhang JF i wsp.: Gene therapy with an adeno-associated
11: 408-18.
virus carrying an interferon gene results in tumor growth
9. Su H i wsp.: Selective-killing of AFP-positive hepatocel- suppression and regression. Cancer Gene Ther 1996; 3:
lular carcinoma cells by adeno-associated virus transfer 31-8.
of the herpes simplex virus thymidine kinase gene. Hum. 20. Hmner JB i wsp.: The efficacy of combination therapy
Gene Ther 1996; 7: 463-70.
using adeno-associated virus-interferon beta and tricho-
10. Bao R, Selvakumaran M, Hamilton TC. Targeted Gene statin A in vitro and in a murine model of neuroblastoma.
Therapy of Ovarian Cancer Using an Ovarian-specific J Ped. Sur 2008; 43: 177-83.
Promoter. Gyn. Oncol 2002; 84: 228-34.
21. Paul D i wsp.: Construction of a recombinant adeno-as-
11. Rohr UP i wsp.: Non-small lung cancer are prime tar- sociated virus (rAAV) vector expressing murine inter-
gets for p53 gene transfer mediated by a recombinant leukin-12 (IL-12) Ther. 2000. 7, s. 308-315.
adeno-associated virus type-2 vector Cancer Gene Ther 22. Liu Y i wsp.: Use and specificity of breast cancer anti-
2003;10: 898-906.
gen/milk protein BA46 for generating anti-self-cytotoxic
12. Nie B i wsp.: AAV-HGFK1 and Ad-p53 cocktail therapy T lymphocytes by recombinant adeno-associated virus-
prolongs survival of mice with colon cancer. Mol. Canbased gene loading of dendritic cells. Cancer Gene Ther
cer Ther 2008;7: 2855-65.
2005; 12: 304-12.
51